Ferring gains option for bladder cancer gene therapy

FKD Therapies Oy (Kuopio, Finland) granted Ferring Pharmaceuticals A/S (Saint-Prex, Switzerland) an option to

Read the full 141 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE